We engage in collaborative research and strategic partnerships:
VAL is actively involved with collaborative research and strategic partnerships with the world’s leading research institutes. Our aim is to enhance the lives of animals and humans through developing high quality monoclonal and polyclonal antibodies for research and clinical applications.
Our experience in antibody technology and established links within the industry allow us to help scientists by:
- Jointly developing research antibodies for their ground-breaking research.
- Jointly developing diagnostic and therapeutic antibodies to human and animal disease.
- Helping to bring their developed products to market.
- Facilitating access to sponsored funding programmes, which require an industrial partner.
Funding schemes available to support our interaction with academic partners: